Senate Drug Pricing Legislation Headed Toward Mid-September Committee Markup

Republican Finance Committee staffer thinks drug pricing legislation will leave most negotiation details up to HHS and try to avoid impact on commercial market.

US Capitol Building, Washington DC
September Will Be Crunch Time For Drug Pricing Legislation

The Senate Finance Committee leadership is planning to mark up drug pricing legislation that would be part of a $3.5 trillion infrastructure bill on Sept. 14 “if not even sooner” to accommodate the aggressive timeline set by the House for voting on the bill, according to a committee staffer.

“We’ll start seeing language in the next few weeks” from the committee on drug pricing reform and “whether that’s where...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access